![Taysha Gene Therapies reports on safety and efficacy results for the first patient to receive gene therapy for Rett Syndrome](/site/assets/files/8746/news_article_-_taysha_1.1500x700.png.webp?nc=1715109017)
On November 29, 2023 Taysha Gene Therapies announced that Health Canada has authorized a protocol amendment to the ongoing REVEAL Phase 1/2 adult trial evaluating TSHA-102 that expands eligibility to include patients aged 12 and older with Rett syndrome.